Ionis: Raising The Bar For ESG
In this episode of Pathfinders, Luca Issi, Senior Biotech Analyst at RBC Capital Markets, speaks with Beth Hougen, CFO of Ionis – a leading innovator in the development of antisense medicines and RNA-targeted therapeutics – to find out how the firm is embedding ESG into its vision, strategy and performance.
Embed this episode
No transcript yet.
Frequently asked questions
How long is this episode of Pathfinders in Biopharma?
This episode is 23 minutes long.
When was this Pathfinders in Biopharma episode published?
This episode was published on October 28, 2021.
Can I download this Pathfinders in Biopharma episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.